Latest Financial Results News

Starpharma reports strong progress in strategic collaborations and internal drug development, alongside a 70% surge in Viraleze™ online sales and a solid $18.2 million cash position.

Knosys reports steady revenue growth and a strategic partnership to upgrade its GreenOrbit platform, while accelerating development of its AI-powered Libero X library solution for a global launch next year.

Appen Limited delivered a robust Q4 FY25, driven by explosive growth in its China segment and strong gains in generative AI projects globally, boosting revenue and profitability significantly.

Betr Entertainment Limited reported a robust 25% headline turnover growth in Q2 FY26 despite a $13.2 million EBITDA loss in H1 due to customer-friendly racing outcomes and strategic investments. The company targets a positive EBITDA turnaround in H2 FY26 and FY27, supported by organic growth, Sky Racing integration, and a new share buyback program.

betr Entertainment reported a $13.2 million EBITDA loss in H1 FY26 due to strategic investments and favourable customer outcomes but projects a strong rebound with a $13-19 million EBITDA target for FY27.

BetMakers Technology Group reported a robust Q2 FY26 with positive adjusted EBITDA and significant contract wins poised to fuel growth in the second half of the year.

Urbanise.com Limited reported a 22% revenue increase in Q2 FY2026, driven by its strategic partnership with National Australia Bank and ongoing development of its Data and Payments Integration Services platform. Despite short-term cash outflows, the company targets positive operating cash flow by FY2027.

6K Additive reported a strong finish to 2025 with a 25% revenue jump in Q4 and secured $31.4 million in IPO proceeds to fuel a fivefold production expansion. The company also landed a $27.4 million US government-backed loan, positioning it for accelerated growth in the additive manufacturing sector.

BetMakers Technology Group reports a robust Q2 FY26 with 14.1% revenue growth and a $2.7 million positive Adjusted EBITDA, underpinned by key partnerships and margin expansion.

Microba Life Sciences reports a 90% year-on-year increase in core microbiome test volumes, driving a 123% rise in core testing revenue to $2.1 million, while advancing clinical adoption and cost efficiencies.

Beam Communications reports a robust $4 million cash position boosted by a recent $9 million divestment of Zoleo Inc., while legacy operations maintain positive cash flow amid revenue shifts.

4DS Memory Limited reports steady progress in its strategic review focused on AI-related opportunities, alongside significant cost reductions and a solid cash position of $8.8 million at the end of December 2025.